Τόμος 34 (2020) – Τεύχος 3 –Άρθρο 5 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 34 (2020) – Issue 3 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Maria Bothou^1,2, Panagiotis Tsikouras³, Georgios Iatrakis⁴, Georgios Tsatsaris³, Nikolaos Platanisiotis^2,5, Evangelia Chatzigianni⁶, Xanthi Anthoulaki³, Anastasia Bothou⁴

¹ Department of Social Work, University of West Attica (UniWA), Athens, Greece

² Community Center, Municipality of Piraeus, Piraeus, Greece

³Department of Obstetrics and Gynecology, Medical Faculty, Democritus University of Thrace, Alexandroupolis, Greece.

⁴ Department of Midwifery, University of West Attica (UniWA), Athens, Greece

⁵ Medical Association of Piraeus, , Piraeus, Greece

⁶ Department of Physiotherapy, University of West Attica (UniWA), Athens, Greece

1. Rodriguez-Morales AJ, Balbin-Ramon GJ, Rabaan AA, Sah R, Dhama K, Paniz-Mondolfi A, Pagliano P, Esposito S. Genomic Epidemiology and its importance in the study of the COVID-19 pandemic. Infez Med. 2020 Ahead of print Jun 1; 28:139-142.
2. Lou J, Tian SJ, Niu SM, Kang XQ, Lian HX, Zhang LX, Zhang JJ. Coronavirus disease 2019: a bibliometric analysis and review. Eur Rev Med Pharmacol Sci. 2020 Mar; 24:3411-3421.
3. Sim MR.The COVID-19 pandemic: major risks to healthcare and other workers on the front line.Occup Environ Med. 2020 May; 77:281-282.
4. Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents. 2020 Mar 28: 105955.
5. Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and Clinical Characteristics of COVID-19.Arch Iran Med. 2020 Apr 1; 23:268-271.
6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance. 2020. https://www.who.int/publicationsdetail/clinicalmanagement-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected (accessed March 9, 2020
7. Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med. 2020 Apr 2.
8. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020 Feb 19.
9. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020 Feb 24.
10. Iatrakis G. Book entitled: High risk pregnancy. Desmos Digital publications. 2020.
11. Andreakos E, Tsiodras S.COVID-19: lambda interferon against viral load and hyperinflammation.EMBO Mol Med. 2020 Apr 25.
12. Li H, Wang YM, Xu JY, Cao B. [Potential antiviral therapeutics for 2019 Novel Coronavirus]. ZhonghuaJie He He Hu Xi ZaZhi. 2020 Mar 12; 43:170-172.
13. Centers for Disease Control and Prevention. Quarantine and isolation. 2017.

https://www.cdc.gov/quarantine/index.html (accessed Jan 30, 2020).

14. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ. The psychological impact of quarantine and how to reduce it: rapid review of the evidence.Lancet. 2020 Mar 14; 395: 912-920.
15. Newman K. Shutt up: bubonic plague and quarantine in early modern England. J Sol Hist. 2012; 45: 809–834.
16. Manuell M-E, Cukor J. Mother Nature versus human nature: public compliance with evacuation and quarantine. Disasters.2011; 35: 417–442.
17. Jeong H, Yim HW, Song Y-J. Mental health status of people isolated due to Middle East respiratory syndrome. Epidemiol Health. 2016; 38: e2016048.
18. Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis. 2004; 10: 1206–1212. L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis. 2004; 10: 1206–1212.
19. Reynolds DL, Garay JR, Deamond SL, Moran MK, Gold W, Styra R. Understanding, compliance and psychological impact of the SARS quarantine experience. Epidemiol Infect. 2008; 136: 997–1007.
20. Mihashi M, Otsubo Y, Yinjuan X, Nagatomi K, Hoshiko M, Ishitake T. Predictive factors of psychological disorder development during recovery following SARS outbreak.Health Psychol. 2009; 28: 91–100.
21. Torales J, O’Higgins M, Castaldelli-Maia JM, Ventriglio A.The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020 Mar 31: 20764020915212.
22. Centers for Disease Control and Prevention (CDC). Coronavirus (COVID-19).

 https://www.cdc.gov/coronavirus/2019-ncov/index.html.

23. Lu W, Wang H, Lin Y, Li L.Psychological status of medical workforce during the COVID-19 pandemic: A cross-sectional study.Psychiatry Res. 2020 Apr 4; 288: 112936.